mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
0.01 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |